These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 9673402

  • 1. Establishment and characterization of an acquired cisplatin-resistant subline in a human osteosarcoma cell line.
    Asada N, Tsuchiya H, Ueda Y, Tomita K.
    Anticancer Res; 1998; 18(3A):1765-8. PubMed ID: 9673402
    [Abstract] [Full Text] [Related]

  • 2. Platinum agents in the treatment of osteosarcoma: efficacy of cisplatin vs. carboplatin in human osteosarcoma cell lines.
    Robson H, Meyer S, Shalet SM, Anderson E, Roberts S, Eden OB.
    Med Pediatr Oncol; 2002 Dec; 39(6):573-80. PubMed ID: 12376980
    [Abstract] [Full Text] [Related]

  • 3. Decreased accumulation of [14C]carboplatin in human cisplatin-resistant cells results from reduced energy-dependent uptake.
    Shen DW, Goldenberg S, Pastan I, Gottesman MM.
    J Cell Physiol; 2000 Apr; 183(1):108-16. PubMed ID: 10699972
    [Abstract] [Full Text] [Related]

  • 4. Transport of cisplatin and bis-acetato-ammine-dichlorocyclohexylamine Platinum(IV) (JM216) in human ovarian carcinoma cell lines: identification of a plasma membrane protein associated with cisplatin resistance.
    Sharp SY, Rogers PM, Kelland LR.
    Clin Cancer Res; 1995 Sep; 1(9):981-9. PubMed ID: 9816070
    [Abstract] [Full Text] [Related]

  • 5. Role of Na+, K+-ATPase alpha1 subunit in the intracellular accumulation of cisplatin.
    Kishimoto S, Kawazoe Y, Ikeno M, Saitoh M, Nakano Y, Nishi Y, Fukushima S, Takeuchi Y.
    Cancer Chemother Pharmacol; 2006 Jan; 57(1):84-90. PubMed ID: 16044341
    [Abstract] [Full Text] [Related]

  • 6. Accumulation, platinum-DNA adduct formation and cytotoxicity of cisplatin, oxaliplatin and satraplatin in sensitive and resistant human osteosarcoma cell lines, characterized by p53 wild-type status.
    Martelli L, Di Mario F, Botti P, Ragazzi E, Martelli M, Kelland L.
    Biochem Pharmacol; 2007 Jun 30; 74(1):20-7. PubMed ID: 17466278
    [Abstract] [Full Text] [Related]

  • 7. De novo deletions of p53 gene and wild-type p53 correlate with acquired cisplatin-resistance in human osteosarcoma OST cell line.
    Asada N, Tsuchiya H, Tomita K.
    Anticancer Res; 1999 Jun 30; 19(6B):5131-7. PubMed ID: 10697522
    [Abstract] [Full Text] [Related]

  • 8. Oxaliplatin in treatment of the cisplatin-resistant MKN45 cell line of gastric cancer.
    Tozawa K, Oshima T, Kobayashi T, Yamamoto N, Hayashi C, Matsumoto T, Miwa H.
    Anticancer Res; 2008 Jun 30; 28(4B):2087-92. PubMed ID: 18751380
    [Abstract] [Full Text] [Related]

  • 9. [Isolation of cisplatin-resistant subline from human ovarian cancer cell line and analysis of its cell-biological characteristics].
    Yoshiya N, Adachi S, Misawa Y, Yuzawa H, Honda T, Kanazawa K, Takeuchi S Tanaka K, Tanaka K.
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Jan 30; 41(1):7-14. PubMed ID: 2647872
    [Abstract] [Full Text] [Related]

  • 10. Characterization of a human squamous carcinoma cell line resistant to cis-diamminedichloroplatinum(II).
    Teicher BA, Holden SA, Kelley MJ, Shea TC, Cucchi CA, Rosowsky A, Henner WD, Frei E.
    Cancer Res; 1987 Jan 15; 47(2):388-93. PubMed ID: 3539321
    [Abstract] [Full Text] [Related]

  • 11. In vitro antitumor activity of a new platinum complex, DWA2114R against human tumor cell lines.
    Akamatsu K, Saito H, Tsunenari T, Matsumoto T, Morikawa K, Koizumi M, Mitsui H, Koizumi K.
    Anticancer Res; 1993 Jan 15; 13(6A):2261-5. PubMed ID: 8297143
    [Abstract] [Full Text] [Related]

  • 12. Potentiating effect of amphotericin B on five platinum anticancer drugs in human cis-diamminedichloroplatinum (II) sensitive and resistant ovarian carcinoma cells.
    Kikkawa F, Kojima M, Oguchi H, Maeda O, Ishikawa H, Tamakoshi K, Mizuno K, Kawai M, Suganuma N, Tomoda Y.
    Anticancer Res; 1993 Jan 15; 13(4):891-6. PubMed ID: 8352556
    [Abstract] [Full Text] [Related]

  • 13. Characterization and resistance mechanisms of cisplatin-resistant human hepatocellular carcinoma cell line.
    Yang JX, Luo Y, Qiu HM, Tang WX.
    Saudi Med J; 2009 Jan 15; 30(1):35-40. PubMed ID: 19139770
    [Abstract] [Full Text] [Related]

  • 14. [Antitumor activity of a new platinum complex, (R)-(-)-2-aminomethylpyrrolidine (1, 1-cyclobutanedicarboxylato) platinum (II), against cisdiamminedichloroplatinum (II)-resistant murine leukemia cell line].
    Akamatsu K, Endo K, Matsumoto T, Kamisango K, Morikawa K, Koizumi M, Mitsui H, Koizumi K, Matsuno T.
    Gan To Kagaku Ryoho; 1990 Jan 15; 17(1):73-8. PubMed ID: 2404458
    [Abstract] [Full Text] [Related]

  • 15. Biochemical characterization of cisplatin-resistance in MKN-45 human stomach adenocarcinoma cell line.
    Hong WS, Son YS.
    Anticancer Res; 1996 Jan 15; 16(5A):3031-6. PubMed ID: 8917423
    [Abstract] [Full Text] [Related]

  • 16. High accumulation of platinum-DNA adducts in strial marginal cells of the cochlea is an early event in cisplatin but not carboplatin ototoxicity.
    Thomas JP, Lautermann J, Liedert B, Seiler F, Thomale J.
    Mol Pharmacol; 2006 Jul 15; 70(1):23-9. PubMed ID: 16569706
    [Abstract] [Full Text] [Related]

  • 17. Characterization of an ovarian carcinoma cell line resistant to cisplatin and flavopiridol.
    Bible KC, Boerner SA, Kirkland K, Anderl KL, Bartelt D, Svingen PA, Kottke TJ, Lee YK, Eckdahl S, Stalboerger PG, Jenkins RB, Kaufmann SH.
    Clin Cancer Res; 2000 Feb 15; 6(2):661-70. PubMed ID: 10690552
    [Abstract] [Full Text] [Related]

  • 18. Human larynx carcinoma cells resistant to cis-diamminedichloroplatinum(II): mechanisms involved in the resistance.
    Beketić-Oresković L, Osmak M, Jaksić M.
    Neoplasma; 1994 Feb 15; 41(3):163-9. PubMed ID: 7935985
    [Abstract] [Full Text] [Related]

  • 19. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI, Boxall FE, Goddard PM, Valenti M, Jones M, Murrer BA, Abrams M, Kelland LR.
    Clin Cancer Res; 1997 Nov 15; 3(11):2063-74. PubMed ID: 9815598
    [Abstract] [Full Text] [Related]

  • 20. Pretreatment with 5-fluorouracil enhances cytotoxicity and retention of DNA-bound platinum in a cisplatin resistant human ovarian cancer cell line.
    Tanaka T, Masuda H, Naito M, Tamai H.
    Anticancer Res; 2001 Nov 15; 21(4A):2463-9. PubMed ID: 11724308
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.